| Ident. | Authors (with country if any) | Title |
|---|
| 000077 (2020) |
Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite] | Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. |
| 000196 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000198 (2020) |
Alexandra C. Walls [États-Unis] ; Young-Jun Park [États-Unis] ; M. Alejandra Tortorici [États-Unis, France] ; Abigail Wall [États-Unis] ; Andrew T. Mcguire [États-Unis] ; David Veesler [États-Unis] | Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein |
| 000199 (2020) |
Jian Shang [États-Unis] ; Yushun Wan [États-Unis] ; Chang Liu [États-Unis] ; Boyd Yount [États-Unis] ; Kendra Gully [États-Unis] ; Yang Yang [États-Unis] ; Ashley Auerbach [États-Unis] ; Guiqing Peng [République populaire de Chine] ; Ralph Baric [États-Unis] ; Fang Li [États-Unis] | Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. |
| 000200 (2020) |
Yun Chen [République populaire de Chine] ; Yao Guo [République populaire de Chine] ; Yihang Pan [République populaire de Chine] ; Zhizhuang Joe Zhao [République populaire de Chine, États-Unis] | Structure analysis of the receptor binding of 2019-nCoV |
| 000201 (2020) |
Swatantra Kumar [Inde] ; Vimal K. Maurya [Inde] ; Anil K. Prasad [Inde] ; Madan L B. Bhatt [Inde] ; Shailendra K. Saxena [Inde] | Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). |
| 000202 (2020) |
Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan] | Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. |
| 000206 (2020) |
Qihui Wang [République populaire de Chine] ; Yanfang Zhang [République populaire de Chine] ; Lili Wu [République populaire de Chine] ; Sheng Niu [République populaire de Chine] ; Chunli Song [République populaire de Chine] ; Zengyuan Zhang [République populaire de Chine] ; Guangwen Lu [République populaire de Chine] ; Chengpeng Qiao [République populaire de Chine] ; Yu Hu [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Qisheng Wang [République populaire de Chine] ; Huan Zhou [République populaire de Chine] ; Jinghua Yan [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] | Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. |
| 000208 (2020) |
Jia Wang [République populaire de Chine] ; Zhifeng Wang [République populaire de Chine] | Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic. |
| 000241 (2020) |
Indwiani Astuti | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response |
| 000274 (2020) |
Janko Nikolich-Zugich [États-Unis] ; Kenneth S. Knox [États-Unis] ; Carlos Tafich Rios [États-Unis] ; Bhupinder Natt [États-Unis] ; Deepta Bhattacharya [États-Unis] ; Mindy J. Fain [États-Unis] | SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes |
| 000315 (2020) |
Yu-Chen Cao [République populaire de Chine] ; Qi-Xin Deng [République populaire de Chine] ; Shi-Xue Dai [République populaire de Chine] | Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence |
| 000366 (2020) |
Boris Krichel ; Sven Falke ; Rolf Hilgenfeld ; Lars Redecke ; Charlotte Uetrecht | Processing of the SARS-CoV pp1a/ab nsp7–10 region |
| 000380 (2020) |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000450 (2020) |
Subramanian Boopathi [Chili] ; Adolfo B. Poma [Pologne] ; Ponmalai Kolandaivel [Inde] | Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. |
| 000453 (2020) |
Anja Holm | New paths for sustainable solutions to tackle global and emerging infectious threats |
| 000459 (2020) |
Youxi Wu [République populaire de Chine] ; Changrui Zhu [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Lei Guo [République populaire de Chine] ; Xindong Wu [République populaire de Chine] | NetNCSP: Nonoverlapping closed sequential pattern mining. |
| 000465 (2020) |
A. A. Dawood | Mutated COVID-19 may foretell a great risk for mankind in the future |
| 000469 (2020) |
Hasanain Abdulhameed Odhar [Iraq] ; Salam Waheed Ahjel [Iraq] ; Ali A. Mohammed Ali Albeer [Iraq] ; Ahmed Fadhil Hashim [Iraq] ; Ali Mahmood Rayshan [Iraq] ; Suhad Sami Humadi [Iraq] | Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus |
| 000517 (2020) |
Ying Yan [République populaire de Chine] ; Le Chang [République populaire de Chine] ; Lunan Wang [République populaire de Chine] | Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. |
| 000521 (2020) |
Maryam Fattahian [Iran] ; Mustafa Ghanadian [Iran] ; Zulfiqar Ali [États-Unis] ; Ikhlas A. Khan [États-Unis] | Jatrophane and rearranged jatrophane-type diterpenes: biogenesis, structure, isolation, biological activity and SARs (1984-2019). |
| 000535 (2020) |
Hossam M. Ashour [États-Unis] ; Walid F. Elkhatib [Égypte] ; Md Masudur Rahman [Bangladesh] ; Hatem A. Elshabrawy [États-Unis] | Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. |
| 000541 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000608 (2020) |
Leila Mousavizadeh [Allemagne] ; Sorayya Ghasemi [Iran] | Genotype and phenotype of COVID-19: Their roles in pathogenesis |
| 000611 (2020) |
Rozhgar A. Khailany [Iraq] ; Muhamad Safdar [Pakistan] ; Mehmet Ozaslan [Turquie] | Genomic characterization of a novel SARS-CoV-2 |
| 000682 (2020) |
Naveen Vankadari [Australie] ; Jacqueline A. Wilce [Australie] | Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. |
| 000719 (2020) |
Jason N. Katz [États-Unis] ; Shashank S. Sinha [États-Unis] ; Carlos L. Alviar [États-Unis] ; David M. Dudzinski [États-Unis] ; Ann Gage [États-Unis] ; Samuel B. Brusca [États-Unis] ; M Casey Flanagan [États-Unis] ; Timothy Welch [États-Unis] ; Bram J. Geller [États-Unis] ; P Elliott Miller [États-Unis] ; Sergio Leonardi [Italie] ; Erin A. Bohula [États-Unis] ; Susanna Price [Royaume-Uni] ; Sunit-Preet Chaudhry [États-Unis] ; Thomas S. Metkus [États-Unis] ; Connor G. O'Brien [États-Unis] ; Alessandro Sionis [Espagne] ; Christopher F. Barnett [États-Unis] ; Jacob C. Jentzer [États-Unis] ; Michael A. Solomon [États-Unis] ; David A. Morrow [États-Unis] ; Sean Van Diepen [Canada] | Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective. |
| 000744 (2020) |
Sheng Cui [République populaire de Chine] ; Wei Hao [République populaire de Chine] | Deducing the Crystal Structure of MERS-CoV Helicase. |
| 000748 (2020) |
Youngchang Kim [États-Unis] ; Robert Jedrzejczak [États-Unis] ; Natalia I. Maltseva [États-Unis] ; Mateusz Wilamowski [États-Unis] ; Michael Endres [États-Unis] ; Adam Godzik [États-Unis] ; Karolina Michalska [États-Unis] ; Andrzej Joachimiak [États-Unis] | Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. |
| 000749 (2020) |
Daniel Wrapp [États-Unis] ; Nianshuang Wang [États-Unis] ; Kizzmekia S. Corbett [États-Unis] ; Jory A. Goldsmith [États-Unis] ; Ching-Lin Hsieh [États-Unis] ; Olubukola Abiona [États-Unis] ; Barney S. Graham [États-Unis] ; Jason S. Mclellan [États-Unis] | Cryo-EM structure of the 2019-nCoV spike in the prefusion
conformation |
| 000751 (2020) |
Burcin Halacli [Turquie] ; Akin Kaya [Turquie] ; Arzu Topeli [Turquie] | Critically-ill COVID-19 patient. |
| 000903 (2020) |
Balachandar Vellingiri [Inde] ; Kaavya Jayaramayya [Inde] ; Mahalaxmi Iyer [Inde] ; Arul Narayanasamy [Inde] ; Vivekanandhan Govindasamy [Inde] ; Bupesh Giridharan [Inde] ; Singaravelu Ganesan [Inde] ; Anila Venugopal [Inde] ; Dhivya Venkatesan [Inde] ; Harsha Ganesan [Inde] ; Kamarajan Rajagopalan [Inde] ; Pattanathu K S M. Rahman [Royaume-Uni] ; Ssang-Goo Cho [Corée du Sud] ; Nachimuthu Senthil Kumar [Inde] ; Mohana Devi Subramaniam [Inde] | COVID-19: A promising cure for the global panic. |
| 000997 (2020) |
Canrong Wu [République populaire de Chine] ; Yang Liu [République populaire de Chine] ; Yueying Yang [République populaire de Chine] ; Peng Zhang [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Yali Wang [République populaire de Chine] ; Qiqi Wang [République populaire de Chine] ; Yang Xu [République populaire de Chine] ; Mingxue Li [République populaire de Chine] ; Xingzhou Li [République populaire de Chine] ; Mengzhu Zheng [République populaire de Chine] ; Lixia Chen [République populaire de Chine] ; Hua Li [République populaire de Chine] | Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods |
| 000A01 (2020) |
Yair Cárdenas-Conejo [Mexique] ; Andr Meda Li An-Rico [Mexique] ; Daniel Alejandro García-Rodríguez [Mexique] ; Sara Centeno-Leija [Mexique] ; Hugo Serrano-Posada [Mexique] | An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2). |
| 000A34 (2020) |
Meng Yuan [États-Unis] ; Nicholas C. Wu [États-Unis] ; Xueyong Zhu [États-Unis] ; Chang-Chun D. Lee [États-Unis] ; Ray T. Y. So [République populaire de Chine] ; Huibin Lv [République populaire de Chine] ; Chris K. P. Mok [République populaire de Chine] ; Ian A. Wilson [États-Unis] | A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV |
| 000A56 (2020) |
Manoj Kumar Gupta [Inde] ; Sarojamma Vemula [Inde] ; Ravindra Donde [Inde] ; Gayatri Gouda [Inde] ; Lambodar Behera [Inde] ; Ramakrishna Vadde [Inde] | In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. |
| 000A68 (2013) |
Kozue Shimabukuro [Japon] ; Makoto Ujike ; Toshihiro Ito ; Hiroshi Tsunemitsu ; Hitoshi Oshitani ; Fumihiro Taguchi | Hemagglutination mediated by the spike protein of cell-adapted bovine torovirus. |
| 000A73 (2010) |
Rui-Fang Li [République populaire de Chine] ; Hong Li | Study on the influences of palindromes in protein coding sequences on the folding rates of peptide chains. |
| 000A74 (2010) |
Shih-Cheng Chen ; René C. L. Olsthoorn | Group-specific structural features of the 5′-proximal sequences of coronavirus genomic RNAs |
| 000A77 (2009) |
Xin Chen [Taïwan] ; Chi-Yuan Chou ; Gu-Gang Chang | Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme. |
| 000B03 (????) |
Ali A. Rabaan [Arabie saoudite] ; Shamsah H. Al-Ahmed [Arabie saoudite] ; Shafiul Haque [Arabie saoudite] ; Ranjit Sah [Népal] ; Ruchi Tiwari [Inde] ; Yashpal Singh Malik [Inde] ; Kuldeep Dhama [Inde] ; M Iqbal Yatoo [Inde] ; D Katterine Bonilla-Aldana ; Alfonso J. Rodriguez-Morales [Colombie] | SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview |
